Determination of GTI-2040, a novel antisense oligonucleotide, in human plasma by using HPLC combined with solid phase and liquid-liquid extractions.

[1]  W. Guo,et al.  Quantification of raf antisense oligonucleotide (rafAON) in biological matrices by LC-MS/MS to support pharmacokinetics of a liposome-entrapped rafAON formulation. , 2005, Biomedical chromatography : BMC.

[2]  D. Dunlop,et al.  Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  J. Marshall,et al.  A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Kolberg,et al.  Structure, function, and mechanism of ribonucleotide reductases. , 2004, Biochimica et biophysica acta.

[5]  A. Levin,et al.  Application of novel quantitative bioanalytical methods for pharmacokinetic and pharmacokinetic/pharmacodynamic assessments of antisense oligonucleotides. , 2004, Current opinion in drug discovery & development.

[6]  V. Lam,et al.  GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors. , 2003, Cancer research.

[7]  E. Eisenhauer,et al.  A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  J. Wright,et al.  The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation. , 1998, Cancer research.

[9]  M. Graham,et al.  Quantitation of phosphorothioate oligonucleotides in human plasma. , 1996, Analytical biochemistry.

[10]  A. Bourque,et al.  Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using direct injection fast anion-exchange chromatography and capillary gel electrophoresis. , 1994, Journal of chromatography. B, Biomedical applications.

[11]  A. Bourque,et al.  Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using fast anion-exchange chromatography. , 1993, Journal of chromatography.